ArticleCNS drugs2022
The Potential of KCNQ Potassium Channel Openers as Novel Antidepressants.
Sara Costi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this papertrialcites it
ArticleCNS drugs2022
Sara Costi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.